News
In people with recently diagnosed type 2 diabetes and no prior cardiovascular disease, self-reported physical activity ...
5h
TipRanks on MSNEli Lilly’s Promising Cancer Therapy Study: A Potential Game-Changer?
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is conducting a clinical ...
With the price of Mounjaro set to almost triple in the UK, there are fears more and more people will turn to counterfeits.
8h
MarketBeat on MSNOzempic Boom: Hims & Eli Lilly Lead Healthcare Bets
Most investors have noticed that most stocks in the healthcare sector have declined to levels not seen in a while, making ...
Johnson & Johnson announces a $2 billion North Carolina manufacturing expansion as part of a broader U.S. onshore ...
Many Mounjaro users have considered making the swap after Eli Lilly announced prices would be increasing in the UK by 170 ...
Indianapolis: Eli Lilly and Company has announced that Anne White, executive vice president and president, Lilly Neuroscience ...
Longer-term data show that donanemab’s cognitive benefits continue to grow over time, and earlier initiation reduces the risk for progression, with no new safety signals.
What goes up must come down — here are the major drugs falling the hardest at the top companies so far this year.
Viking Therapeutics' stock drops 40% despite strong Phase 2 weight-loss drug results. See here to know why I remain ultra ...
A rumor that pharmaceutical companies behind popular weight-loss and diabetes medications like Ozempic faced lawsuits totaling more than $2 billion circulated online in August 2025. Claims of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results